Search PubMedSearch

PubMed · 42736022

Conflict-dependent gain control in area VIP during visual-vestibular self-motion processing.

Abstract

Visual and vestibular signals are continuously integrated to estimate self-motion, yet these sensory cues are often inconsistent under natural conditions. How cortical circuits regulate multisensory interactions under cue conflict while preserving stable heading representations remains poorly understood. Here, we recorded neurons in male macaque ventral intraparietal area (VIP) during passive movement stimulation while systematically varying visual-vestibular heading offsets. VIP neurons exhibited strong conflict-sensitive gain modulation: congruent cues enhanced neuronal responses, whereas increasing cue offsets progressively suppressed response gain. This effect was observed not only in multisensory neurons but also in neurons classified as predominantly visual or vestibular, indicating widespread cross-modal interactions across the population. In contrast, preferred-heading shifts remain modest, suggesting that cue conflict primarily modulated response gain rather than altering heading tuning. Despite substantial suppression at the single-neuron level under large cue offsets, population Fisher information was largely preserved, indicating robust heading discriminability. Further analyses revealed flexible sensory weighting in VIP, with visual and vestibular contributions shifting as cue conflict increased. Finally, a feedforward-gated normalization model substantially improved the characterization of VIP responses by allowing cue conflict to dynamically regulate the effective normalization pool, thereby capturing both multisensory enhancement at small visual-vestibular heading offset and suppression under large cue conflict. Together, these findings show that VIP exhibits conflict-dependent regulation of multisensory gain, preserving robust self-motion representations under sensory conflict.Significance statement Visual and vestibular cues are often misaligned in natural environments, creating a challenge for accurate self-motion perception. We demonstrate that neurons in the macaque ventral intraparietal area (VIP) dynamically adjust multisensory gain according to the degree of visual-vestibular conflict. As the visual-vestibular heading offset increases, neuronal responses are progressively enhanced or suppressed, while population coding of heading direction remains largely preserved. A conflict-sensitive normalization model accounts for these response dynamics and outperforms traditional multisensory integration models, suggesting that VIP implements adaptive gain-control computations to regulate interactions between visual and vestibular signals. These results identify a cortical mechanism that links sensory conflict detection to robust perceptual coding, advancing our understanding of multisensory processing in the brain.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Huizhe Sun, Rong Wang, Fu Zeng, Aihua Chen. 2026-09-14. Conflict-dependent gain control in area VIP during visual-vestibular self-motion processing.. https://doi.org/10.1523/jneurosci.0975-26.2026

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article